Literature DB >> 11835530

Cytokine serum levels in patients with chronic HCV infection.

Nick E Spanakis1, George A Garinis, Evangelos C Alexopoulos, George P Patrinos, Panayotis G Menounos, Alexandra Sklavounou, Evangelos N Manolis, Vassilis G Gorgoulis, Dimitrios Valis.   

Abstract

The pathogenic role of immune-mediated mechanisms in chronic hepatitis C virus (HCV) infection has not yet been elucidated. In this study, we report different cytokine expression profiles from hemodialysis (HD) and non-HD HCV (+) patients. IL-1beta, IL-2, IL-4, IL-6, TNF-alpha, and TGF-beta1 serum levels, and liver biochemical parameters were determined in 85 individuals (41 HD patients and 44 non-HD patients). Screening for HCV RNA and anti-HCV antibodies was performed using qualitative and quantitative reverse transcription polymerase chain reaction (RT-PCR), and standardized enzyme-linked immunosorbent assay (ELISA) and recombinant immunoblot assay (RIBA) methods, respectively. IL-4 and IL-1beta demonstrated decreased serum levels in non-HD HCV carriers compared with healthy controls. Both T helper (Th) 1 and Th2 lymphocytes were highly associated with chronic HCV infection, as indicated by the increased IL-2, IL-4, and IL-6 cytokine circulating levels in all chronic active hepatitis (CAH) patients examined. An enhanced Th2 response (IL-4 and IL-6) coupled with increased TNF-alpha and IL-1beta serum levels was reported in HD HCV (-) patients. In conclusion, our data show that a virus-induced Th2 and IL-1beta immunosuppression is an early event in HCV-related chronicity. Long-term HD specifically exerts a chronic effect on IL-6, IL-1beta, and TNF-alpha serum circulating levels. Irrespective of the HD status, HCV viremia, and liver biochemistry parameters, both Th1 and Th2 responses are highly associated with chronic HCV infection. Copyright 2002 Wiley‐Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835530      PMCID: PMC6808060          DOI: 10.1002/jcla.2060

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  20 in total

1.  Evaluation of a minipool reverse transcription-PCR screening method for the detection of hepatitis C virus infection in hemodialysis patients.

Authors:  G Garinis; G P Patrinos; P Menounos; N Spanakis; V G Gorgoulis; V Theodorou; T Ioannidis; A Karameris; D Valis
Journal:  Clin Chem       Date:  2000-04       Impact factor: 8.327

Review 2.  The expanding universe of T-cell subsets: Th1, Th2 and more.

Authors:  T R Mosmann; S Sad
Journal:  Immunol Today       Date:  1996-03

Review 3.  Hepatitis C and hepatocellular carcinoma.

Authors:  A M Di Bisceglie
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  In vivo induction of interleukin-1 during hemodialysis.

Authors:  N Haeffner-Cavaillon; J M Cavaillon; C Ciancioni; F Bacle; S Delons; M D Kazatchkine
Journal:  Kidney Int       Date:  1989-05       Impact factor: 10.612

Review 5.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation.

Authors:  D D Eckels; N Tabatabail; T H Bian; H Wang; S S Muheisen; C M Rice; K Yoshizawa; J Gill
Journal:  Hum Immunol       Date:  1999-03       Impact factor: 2.850

7.  Inhibition of the constitutive and induced IFN-beta production by IL-4 and IL-10 in murine peritoneal macrophages.

Authors:  B Varano; L Fantuzzi; P Puddu; P Borghi; F Belardelli; S Gessani
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

Review 8.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Cytokine Growth Factor Rev       Date:  1997-12       Impact factor: 7.638

9.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

10.  Haemodialysis membranes modulate chronically the production of TNF alpha, IL1 beta and IL6.

Authors:  J L Mege; M Olmer; R Purgus; P Bertocchio; C Farnarier; S Kaplanski; C Capo; P Bongrand
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

View more
  14 in total

1.  Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection.

Authors:  James A Harker; Gavin M Lewis; Lauren Mack; Elina I Zuniga
Journal:  Science       Date:  2011-09-29       Impact factor: 47.728

2.  Cytokine responses in acute and persistent human parvovirus B19 infection.

Authors:  A Isa; A Lundqvist; A Lindblom; T Tolfvenstam; K Broliden
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

3.  Increased Spontaneous Programmed Cell Death Is Associated with Impaired Cytokine Secretion in Peripheral Blood Mononuclear Cells from Hepatitis C Virus-Positive Patients.

Authors:  Abdulkarim Alhetheel; Ahmed Albarrag; Zahid Shakoor; Khalid Alswat; Ayman Abdo; Waleed Al-Hamoudi; Suliman Alomar
Journal:  Viral Immunol       Date:  2017-03-17       Impact factor: 2.257

Review 4.  Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics.

Authors:  Basri Satilmis; Tevfik Tolga Sahin; Egemen Cicek; Sami Akbulut; Sezai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2021-10-08

5.  Impaired toll-like receptor 3-mediated immune responses from macrophages of patients chronically infected with hepatitis C virus.

Authors:  Feng Qian; Christopher R Bolen; Chunxia Jing; Xiaomei Wang; Wei Zheng; Hongyu Zhao; Erol Fikrig; R Douglas Bruce; Steven H Kleinstein; Ruth R Montgomery
Journal:  Clin Vaccine Immunol       Date:  2012-12-05

6.  Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders.

Authors:  Luigi Buonaguro; Annacarmen Petrizzo; Marialina Tornesello; Maria Napolitano; Debora Martorelli; Giuseppe Castello; Gerardo Beneduce; Amalia De Renzo; Oreste Perrella; Luca Romagnoli; Vitor Sousa; Valli De Re; Riccardo Dolcetti; Franco M Buonaguro
Journal:  J Transl Med       Date:  2010-02-19       Impact factor: 5.531

Review 7.  Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma.

Authors:  Lydia Giannitrapani; Maurizio Soresi; Daniele Balasus; Anna Licata; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

Review 8.  Underlying pathophysiology of HCV infection in HIV-positive drug users.

Authors:  Anuradha Balasubramanian; Jerome E Groopman; Ramesh K Ganju
Journal:  J Addict Dis       Date:  2008

9.  Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.

Authors:  M C Villacres; O Literat; M DeGiacomo; W Du; T Frederick; A Kovacs
Journal:  J Viral Hepat       Date:  2008-02       Impact factor: 3.728

10.  Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10.

Authors:  Soriane de Souza-Cruz; Marilú Barbieri Victória; Andréa Monteiro Tarragô; Allyson Guimarães da Costa; João Paulo Diniz Pimentel; Ericka Florêncio Pires; Lorene de Paula Araújo; Jordana Grazziela Coelho-dos-Reis; Matheus de Souza Gomes; Laurence Rodrigues Amaral; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Flamir da Silva Victória; Adriana Malheiro
Journal:  BMC Microbiol       Date:  2016-01-07       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.